clarithromycin has been researched along with Hemorrhagic Fever, Ebola in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaüzère, BA; Malvy, D | 1 |
| Fisher, E; García-Sastre, A; He, S; Kouznetsova, J; Long, Y; Martínez-Romero, C; Motabar, O; Qiu, X; Sanderson, PE; Shinn, P; Sun, W; Tawa, G; Williamson, PR; Xu, M; Yang, S; Zheng, W | 1 |
2 other study(ies) available for clarithromycin and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
[Vingt-cinquième réunion du comité local de la Société de pathologie exotique, 24 novembre 2015].
Topics: Clarithromycin; Drug Resistance, Microbial; Guinea; Helicobacter Infections; Hemorrhagic Fever, Ebola; Histoplasmosis; Hospitalization; Humans; Influenza, Human; Leprosy; Otorhinolaryngologic Neoplasms; Reunion; Severity of Illness Index; Tropical Medicine | 2016 |
Synergistic drug combination effectively blocks Ebola virus infection.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Clarithromycin; Drug Combinations; Drug Synergism; Ebolavirus; Hemorrhagic Fever, Ebola; High-Throughput Screening Assays; Humans; Mefloquine; Sphingomyelin Phosphodiesterase; Toremifene; Triazoles; Vero Cells; Virus Internalization | 2017 |